Simplex Trading
VERV

Simplex Trading’s Verve Therapeutics VERV Stock Holding History

Simplex Trading’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$2K – 10157
2025
Q2 		$2K Sell
200
-2,900
-94% -$16.5K ﹤0.01% 8223
2025
Q1 		$14K Buy
3,100
+700
+29% +$4.69K ﹤0.01% 6865
2024
Q4 		$13K Buy
+2,400
New +$13.5K ﹤0.01% 7035
2024
Q3 		– Sell
-1,700
Closed -$8K – 9669
2024
Q2 		$8K Sell
1,700
-7,500
-82% -$47.1K ﹤0.01% 7623
2024
Q1 		$122K Buy
9,200
+2,500
+37% +$33.2K ﹤0.01% 5384
2023
Q4 		$93K Buy
6,700
+4,200
+168% +$52.1K ﹤0.01% 5462
2023
Q3 		$33K Buy
2,500
+2,000
+400% +$32.2K ﹤0.01% 6184
2023
Q2 		$9K Sell
500
-200
-29% -$3.33K ﹤0.01% 7531
2023
Q1 		$10K Sell
700
-17,000
-96% -$333K ﹤0.01% 7573
2022
Q4 		$342K Buy
17,700
+1,500
+9% +$39.7K ﹤0.01% 3580
2022
Q3 		$556K Buy
16,200
+12,000
+286% +$383K ﹤0.01% 3352
2022
Q2 		$64K Buy
4,200
+3,800
+950% +$58.9K ﹤0.01% 6174
2022
Q1 		$9K Sell
400
-400
-50% -$11.4K ﹤0.01% 8984
2021
Q4 		$29K Buy
+800
New +$33.6K ﹤0.01% 7958

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's VERV Position: Q3 2025 in Review

Simplex Trading sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 81,129 shares — an estimated $911K sold.

Simplex Trading first reported a position in VERV in Q4 2021 and held it in 10 quarters. The position peaked at $911K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Simplex Trading reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 81,129 Verve Therapeutics shares in Q3 2025, an estimated $911K.
  • Simplex Trading first reported a position in Verve Therapeutics in Q4 2021 and held it in 10 quarters.
  • Simplex Trading's Verve Therapeutics position peaked at $911K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.